Form 13-F position report

GILEAD SCIENCES INC

Reported by Quantessence Capital LLC

GILD CUSIP 375558103 Manager CIK 0002009590

First reported at 66,283 shares this quarter.

New
% of reported 13F value 1.86% This manager · Q1 2025
Shares 66,283 Quarter-end amount reported
Reported value $7,427,010 Fair value at quarter end
Consecutive quarters held 1 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 7427010
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by Quantessence Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -66,283 (-100.0%) 0 $0 2025-08-14
Q1 2025 New 66,283 +66,283 (0.0%) 1.86% $7,427,010 2025-05-15

Who else reported the position

2136 managers reported GILEAD SCIENCES INC for Q1 2025.

Managers reporting GILEAD SCIENCES INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 117,470,825 +1,942,433 0.24% $13,162,605,942 48 qtrs
BlackRock Inc Reduced 116,104,572 -4,251,269 0.27% $13,009,517,311 3 qtrs
STATE STREET CORPORATION Reduced 59,523,675 -858,080 0.27% $6,669,627,784 48 qtrs
FMR LLC Added 58,542,842 +18,223,410 0.42% $6,559,725,439 48 qtrs
Capital Research Global Investors Reduced 54,610,370 -3,335,858 1.33% $6,119,089,714 48 qtrs
Capital World Investors Reduced 53,547,901 -18,158,461 0.97% $5,999,969,494 48 qtrs
Dodge & Cox Reduced 32,694,791 -252,926 2.09% $3,663,451,332 43 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 28,480,147 +190,230 0.25% $3,187,711,955 48 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 27,358,967 -8,300,040 0.59% $3,065,572,254 48 qtrs
NORGES BANK Added 19,855,810 +485,300 0.31% $2,224,843,511 48 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
66,283
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.